A patient submitted outside study for review. Submitted for review are breast MRI dated 6/27/2016 performed at Palos community Hospital. Outside hospital MRI uploaded to Dyna CAD for postprocessing and interpretation. As per the report from outside hospital 20 cc of MultiHance was administered intravenously.Fatty breast tissue noted bilaterally. Mild parenchymal enhancement is present.Lobulated enhancing mass at the site of proven right central breast malignancy measures 2.1 x 1.1 cm. Clip artifact is identified within the lobulated mass. Predominantly superior to the enhancing mass, there is an area of fat density with peripheral thin enhancement, compatible with postbiopsy fat necrosis/hematoma. A somewhat nodular area of enhancement at the superior aspect of the fat necrosis is seen though this may represent post biopsy changes rather than tumor. Additionally, about 3 cm lateral and posterior to the known malignancy is a 6 mm intramammary lymph node, with a normal fatty hilum on the fat sensitive sequence and expected enhancement. Within the inferior breast, there are 2 several millimeter sized foci of enhancement that do not meet threshold for kinetic analysis on our system. No suspicious axillary lymph node in either axilla. Normal parenchymal enhancement is noted in the left breast.
1. Biopsy-proven malignancy in the right breast measures up to 2.1 cm. Adjacent hematoma/fat necrosis is noted.2. Normal sized intramammary lymph node in the right upper outer quadrant has expected MRI appearance on contrast enhanced and fat sensitive sequences.3. A few scattered foci in the inferior right breast do not meet threshold for kinetic analysis and are probably benign. Suggest a 6 month MRI and mammogram follow-up to ensure stability.BIRADS: 6 - Known cancer.RECOMMENDATION: T - Take Appropriate Action - No Letter.